Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS
How to Cite
OrthoEvidence. Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS. ACE Report. 2019;8(3):10. Available from: https://myorthoevidene.com/AceReport/Report/10871
Sativex as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trialInt J Neurosci. 2018 Sep 13:1-10.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
106 patients with resistant multiple sclerosis who had demonstrated adequate treatment response to Sativex (tetrahydrocannabinol and cannabidiol oromucosal spray) treatment in a 4-week trial phase were randomized to Sativex or placebo for 12 weeks after 1-4 week washout from the trial phase. The purpose of the study was to determine if tetrahydrocannabinol and cannabidiol oromucosal spray (THC:CBD...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE